Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.

Truitt, Kenneth E et al.·Alimentary pharmacology & therapeutics·2019·
RPEP-045242019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.
Published In:
Alimentary pharmacology & therapeutics, 50(5), 547-555 (2019)
Database ID:
RPEP-04524

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04524·https://rethinkpeptides.com/research/RPEP-04524

APA

Truitt, Kenneth E; Daveson, A James M; Ee, Hooi C; Goel, Gautam; MacDougall, James; Neff, Kristin; Anderson, Robert P. (2019). Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.. Alimentary pharmacology & therapeutics, 50(5), 547-555. https://doi.org/10.1111/apt.15435

MLA

Truitt, Kenneth E, et al. "Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.." Alimentary pharmacology & therapeutics, 2019. https://doi.org/10.1111/apt.15435

RethinkPeptides

RethinkPeptides Research Database. "Randomised clinical trial: a placebo-controlled study of sub..." RPEP-04524. Retrieved from https://rethinkpeptides.com/research/truitt-2019-randomised-clinical-trial-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.